14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 BPMC stock ended at $106.25. This is 0.88% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 2.87% from a day low at $105.48 to a day high of $108.51.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
Mar 31, 2023 $44.66 $45.74 $44.32 $44.99 470 742
Mar 30, 2023 $45.56 $45.98 $43.80 $44.29 429 110
Mar 29, 2023 $42.92 $45.30 $42.47 $44.97 573 220
Mar 28, 2023 $43.15 $43.67 $42.40 $42.57 367 440
Mar 27, 2023 $43.61 $45.00 $43.19 $43.32 406 623
Mar 24, 2023 $43.18 $43.75 $42.33 $43.48 494 363
Mar 23, 2023 $44.00 $45.38 $42.77 $43.61 601 540
Mar 22, 2023 $45.37 $45.96 $43.42 $43.52 478 011
Mar 21, 2023 $46.19 $46.63 $45.18 $45.52 446 768
Mar 20, 2023 $44.88 $45.58 $44.08 $45.31 362 548
Mar 17, 2023 $44.76 $45.63 $44.00 $45.09 999 165
Mar 16, 2023 $45.05 $45.92 $44.01 $44.99 627 807
Mar 15, 2023 $45.78 $46.90 $44.75 $45.16 462 038
Mar 14, 2023 $44.83 $46.64 $44.27 $46.36 841 486
Mar 13, 2023 $41.56 $44.56 $41.56 $43.82 582 816
Mar 10, 2023 $43.21 $43.21 $40.48 $42.00 729 648
Mar 09, 2023 $43.89 $44.41 $42.60 $43.16 487 993
Mar 08, 2023 $44.42 $44.64 $43.31 $43.90 366 196
Mar 07, 2023 $43.22 $44.79 $42.51 $44.43 458 049
Mar 06, 2023 $45.72 $46.65 $43.06 $43.42 1 264 475
Mar 03, 2023 $43.68 $48.95 $43.68 $47.45 1 442 149
Mar 02, 2023 $42.83 $43.56 $42.25 $43.21 520 654
Mar 01, 2023 $42.56 $44.04 $42.44 $43.15 487 748
Feb 28, 2023 $40.53 $43.06 $40.30 $42.37 906 778
Feb 27, 2023 $38.38 $40.73 $38.33 $40.52 1 311 501
Click to get the best stock tips daily for free!

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT